Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
GNPTAB encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. Additionally we are shipping GNPTAB Proteins (4) and many more products for this protein.
Showing 10 out of 37 products:
The DMAP interaction domain of the alpha subunit (show POLG Antibodies) functions in the selective recognition of acid hydrolase substrates and provides an explanation for the impaired phosphorylation of acid hydrolases in a patient with mucolipidosis II.
GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II
GNPTAB mutations are associated with mucolipidosis II.
Mutations of the GNPTAB gene is associated with mucolipidosis type III.
we described five individuals from a large consanguineous Turkish family with MLIIIalpha/beta and identified a novel homozygous missense genetic variant in the alpha subunit (show POLG Antibodies) of GNPTAB gene in five patients
Persistent stuttering is associated with mutations in GNPTAB that are generally not found in mucolipidosis .
GlcNAc-1-phosphotransferase gamma (show GNPTG Antibodies)-subunits bind to glycosylated region in the no-similarity domain 2 of alpha-subunit (show POLG Antibodies), which is independent on cysteine 70 identified to be responsible for alpha-subunit (show POLG Antibodies) homodimerization.
SNPs covering GNPTAB, GNPTG (show GNPTG Antibodies) and NAGPA (show NAGPA Antibodies) were subjected to genotyping, association analysis was performed on all SNPs. Significant association of rs17031962 in GNPTAB and rs882294 in NAGPA (show NAGPA Antibodies) with developmental dyslexia in a Chinese population was identified after false discovery rate correction for multiple comparisons.
A novel intermediate mucolipidosis II/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain.
novel mouse model of MLII homozygous for a patient mutation in the GNPTAB gene.
both missense and frameshift mutations are associated with a severe clinical phenotype causing retention of the protein in the endoplasmic reticulum and failure to cleave the alpha/beta-subunit (show POLG Antibodies) precursor protein are associated with a severe clinical phenotype
Retinal degeneration with storage disease phenotype in most exocrine glands in Gnptab null mice
This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
, N-acetylglucosamine-1-phosphotransferase subunits alpha/beta
, stealth protein gnptab
, glcNAc-1-phosphotransferase subunits alpha/beta
, UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta
, N-acetylglucosamine-1-phosphotransferase subunits alpha/beta-like
, n-acetylglucosamine-1-phosphotransferase subunits alpha/beta-like
, GlcNAc phosphotransferase
, UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosamine
, glucosamine (UDP-N-acetyl)-lysosomal-enzyme N-acetylglucosamine phosphotransferase
, stealth protein GNPTAB